Functional-structural reorganisation of salivary glands in oncological pathology: A mini-review
DOI:
https://doi.org/10.61751/bmbr/3.2024.60Keywords:
oncology, dysfunction, chemotherapy, morphometry, radiationAbstract
Dysfunctions of salivary glands during the treatment of benign and malignant tumours are a widely diagnosed problem among oncology patients. This study aimed to investigate the disruption of the structure of salivary glands as a result of the treatment of oncological diseases and methods for their correction and elimination. 39 scientific papers
were analysed. Methods of search, comparison, systematisation, and combination of the results of the conducted studies were used. The destructive effect of chemo- and radiotherapy and the treatment of malignant tumours by increasing the body’s overall temperature on the structure of salivary glands in the experiment was proven. The influence of lowintensity ultrasound on the submandibular gland demonstrates its tissues’ high adaptive and regenerative properties. Data from clinical studies on the correction and elimination of salivary gland dysfunctions in oncological patients showed an ambiguous result. The simultaneous application of photobiomodulation and radiotherapy in patients with head and neck tumours significantly improves organ function: it stimulates salivation, regulates saliva composition, controls the redox mechanism of salivary glands, and locally eliminates inflammation. A slight compensation of the mineralising function of saliva was found with substitution therapy using biologically active components and a remineralising agent in children with malignant tumours undergoing chemotherapy. A positive effect of betanechol and vitamin E in protecting salivary glands during the treatment of head and neck cancer with radiotherapy has been noted, which consists of improving the structure and function of the glands in the long term and is the same in women and men. Studies of vitamin C intake after radioiodine therapy in patients with head and neck cancer have shown its insufficient restorative effect on the quantitative and qualitative composition of saliva. The results of this review can serve as a basis for an accurate assessment by oncologists of salivary gland damage and the pathogenesis of their dysfunctions as a result of cancer therapy, provide an opportunity to reconsider existing views on the problem, develop new methods for preventing and treating these complications, and improve the quality of life and recovery process for patients
Received: 06.05.2024 | Revised: 19.07.2024 | Accepted: 30.08.2024
References
Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–49. DOI: 10.3322/caac.21660
Schleicher SM, Bach PB, Matsoukas K, Korenstein D. Medication overuse in oncology: Current trends and future implications for patients and society. Lancet Oncol. 2018;19(4). DOI: 10.1016/S1470-2045(18)30099-8
Kyaw JYA, Rendall A, Gillespie EF, Roques T, Court L, Lievens Y, et al. Systematic review and meta-analysis of the association between radiation therapy treatment volume and patient outcomes. Int J Radiat Oncol Biol Phys. 2023;117(5):1063–86. DOI: 10.1016/j.ijrobp.2023.02.048
Gevkaliuk N, Sydliaruk N, Posolenyk L, Vydoinyk O, Kuchyrka L. The state of oxidative homeostasis in children with influenza stomatitis. Wiad Lek. 2019;72(3):405–8.
Deshpande T, Gunn GB, Fuller CD, Ye R, Rosenthal DI, Garden AS, et al. Xerostomia impacts dysgeusia in oropharyngeal cancer patients treated with proton therapy. Int J Radiat Oncol Biol Phys. 2019;105(1). DOI: 10.1016/j.ijrobp.2019.06.1517
Galaniha LT, Nolden AA. The role of saliva in taste dysfunction among cancer patients: Mechanisms and potential treatment. Oral Oncol. 2022;133:106030. DOI: 10.1016/j.oraloncology.2022.106030
Iijima Y, Yamada M, Endo M, Sano M, Hino S, Kaneko T, Horie N. Dysgeusia in patients with cancer undergoing chemotherapy. J Oral Maxillofac Surg Med Pathol. 2019;31(3):214–17. DOI: 10.1016/j.ajoms.2019.01.006
Silva IMV, Donaduzzi LC, Perini CC, Couto SAB, Werneck RI, de Araújo MR, et al. Association of xerostomia and taste alterations of patients receiving antineoplastic chemotherapy: A cause for nutritional concern. Clin Nutr ESPEN. 2021;43:532–35. DOI: 10.1016/j.clnesp.2021.03.006
Brook I. Late side effects of radiation treatment for head and neck cancer. Radiat Oncol J. 2020;38(2):84–92. DOI: 10.3857/ROJ.2020.00213
Riantiningtyas RR, Valenti A, Dougkas A, Bredie WLP, Kwiecien C, Bruyas A, Giboreau A, Carrouel F. Oral somatosensory alterations and salivary dysfunction in head and neck cancer patients. Support Care Cancer. 2023;31(12):627. DOI: 10.1007/s00520-023-08086-7
Huang Z, Chen Y, Pan L, Feng H, Wu J, Chen P, Wang J, Ouyang W. Progressive changes in the major salivary gland after radioiodine therapy for differentiated thyroid cancer: A single-center retrospective ultrasound cohort study. Ultrasound Med Biol. 2021;47(9):2514–22. doi: 10.1016/j.ultrasmedbio.2021.05.013
Klein BA, Alves FA, de Santana Rodrigues Velho J, Vacharotayangul P, Hanna GJ, et al. Oral manifestations of immune-related adverse events in cancer patients treated with immune checkpoint inhibitors. Oral Dis. 2022;28(1):9–22. DOI: 10.1111/odi.13964
Herashchenko S, Hvozdyk I, Dyelʹtsova O. Morpho-functional changes of the submandibular gland under the influence of cisplatin and their correction with enterosgel in the experiment. Sci Bull Uzhhorod Univ. 2010;(38):7–11.
Willems RAL, Winckers K, Biesmans C, de Vos-Geelen J, ten Cate H. Evolving data on cardiovascular complications in cancer. Thromb Res. 2022;213(Suppl 1). DOI: 10.1016/j.thromres.2022.01.003
Kirwan CC, Blower EL. Contemporary breast cancer treatment-associated thrombosis. Thromb Res. 2022;213(Suppl 1):8–15. DOI: 10.1016/j.thromres.2021.12.025
Farokh A, Pourmadadi M, Rashedi H, Yazdian F, Navaei-Nigjeh M. Assessment of synthesized chitosan/halloysite nanocarrier modified by carbon nanotube for pH-sensitive delivery of curcumin to cancerous media. Int J Biol Macromol. 2023;237:123937. DOI: 10.1016/j.ijbiomac.2023.123937
Bomeli SR, Desai SC, Johnson JT, Walvekar RR. Management of salivary flow in head and neck cancer patients – a systematic review. Oral Oncol. 2008;44(11):1000–8. DOI: 10.1016/j.oraloncology.2008.02.007
Radfar L, Sirois DA. Structural and functional injury in minipig salivary glands following fractionated exposure to 70 Gy of ionizing radiation: An animal model for human radiation-induced salivary gland injury. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2003;96(3):267–74. DOI: 10.1016/S1079-2104(03)00369-X
Huisman F, Van Elst JM, Reyners AKL, De Haan JJ, Oei M, Visser O, Kramer EPA. Taste and smell changes resulting from cancer therapies. Ned Tijdschr Geneeskd. 2021;165:D5696.
Mercadante V, Jensen SB, Smith DK, Bohlke K, Bauman J, Brennan MT, et al. Salivary gland hypofunction and/or xerostomia induced by nonsurgical cancer therapies: ISOO/MASCC/ASCO guideline. J Clin Oncol. 2021;39(25):2825–43. DOI: 10.1200/JCO.21.01208
Bidram E, Esmaeili Y, Ranji-Burachaloo H, Al-Zaubai N, Zarrabi A, Stewart A, Dunstan DE. A concise review on cancer treatment methods and delivery systems. J Drug Deliv Sci Technol. 2019;54:101350. DOI: 10.1016/j.jddst.2019.101350
de Lucas B, Pérez LM, Bernal A, Gálvez BG. Ultrasound therapy: Experiences and perspectives for regenerative medicine. Genes. 2020;11(9):1086. DOI: 10.3390/genes11091086
Tarasenko L, Bilets M. Mechanisms of oral cavity tissues stress damages (a brief review of the literature and our own research). Ukr Dent Almanac. 2016;2(1):23–25.
Patel VN, Hoffman MP. Salivary gland development: A template for regeneration. Semin Cell Dev Biol. 2014;25-26:52–60. DOI: 10.1016/j.semcdb.2013.12.001
Louzeiro GC, Cherubini K, de Figueiredo MA, Salum FG. Effect of photobiomodulation on salivary flow and composition, xerostomia and quality of life of patients during head and neck radiotherapy in short term follow-up: A randomized controlled clinical trial. J Photochem Photobiol B. 2020;209:111933. DOI: 10.1016/j.jphotobiol.2020.111933
Debela DT, Muzazu SG, Heraro KD, Ndalama MT, Mesele BW, Haile DC, et al. New approaches and procedures for cancer treatment: Current perspectives. SAGE Open Med. 2021;9. DOI: 10.1177/20503121211034366
Roth P, Winklhofer S, Müller AMS, Dummer R, Mair MJ, Gramatzki D, et al. Neurological complications of cancer immunotherapy. Cancer Treat Rev. 2021;97:102189. DOI: 10.1016/j.ctrv.2021.102189
Tkachenko P, Kaskova L, Popelo Y. Correction of speed of salivation and mineralizing potential of the oral fluid in children with malignant tumors of soft tissues, who receive chemotherapy. Ukr Dent Almanac. 2015;5:65–70.
Nolden AA, Hwang L-D, Boltong A, Reed DR. Chemosensory changes from cancer treatment and their effects on patients’ food behavior: A scoping review. Nutrients. 2019;11(10):2285. DOI: 10.3390/nu11102285
Larsen AK, Thomsen C, Sanden M, Skadhauge LB, Anker CB, Mortensen MN, Bredie WLP. Taste alterations and oral discomfort in patients receiving chemotherapy. Support Care Cancer. 2021;29(12):7431–39. DOI: 10.1007/s00520-021-06316-4
Manoharan S, Thangavelu L, Dua K, Chellappan DK. Advanced drug delivery systems in oral cancer. In: Advanced drug delivery systems in the management of cancer. New York: Academic Press 2021; p. 235–42. DOI: 10.1016/B978-0-323-85503-7.00022-5
Campagna S, Gonella S, Sperlinga R, Giuliano PL, Marchese R, Pedersini R, et al. Prevalence, severity, and self-reported characteristics of taste alterations in patients receiving chemotherapy. Oncol Nurs Forum. 2018;45(3):342–53. DOI: 10.1188/18.ONF.342-353
Campanhã D, Pereira Lima EN, Alves FA, Jaguar GC. Bethanechol used to prevent salivary gland dysfunction in patients submitted to radioactive iodine therapy: A double-blind, placebo-controlled, randomized study. J Stomatol Oral Maxillofac Surg. 2022;123(5): 626–30. DOI: 10.1016/j.jormas.2021.12.014
Upadhyaya A, Meng Z, Wang P, Zhang G, Jia Q, Tan J, et al. Effects of first radioiodine ablation on functions of salivary glands in patients with differentiated thyroid cancer. Medicine (Baltimore). 2017;96(25). DOI: 10.1097/MD.0000000000007164
Buttiron Webber T, Briata IM, DeCensi A, Cevasco I, Paleari L. Taste and smell disorders in cancer treatment: Results from an integrative rapid systematic review. Int J Mol Sci. 2023;24(3):2538. DOI: 10.3390/ijms24032538
Tchelebi LT, Shen B, Wang M, Gusani NJ, Walter V, Abrams R, et al. Impact of radiation therapy facility volume on survival in patients with cancer. Cancer. 2021;127(21):4081–90. DOI: 10.1002/cncr.33777
Liu Y, Wang Y, Zhang W. Optimal administration time of vitamin C after 131I therapy in differentiated thyroid cancer based on propensity score matching. Front Surg. 2022;9:993712. DOI: 10.3389/fsurg.2022.993712
Hayek G, Kastler B. Interventional radiology for treatment of bone metastases. Cancer. 2020;24(5):374–78. DOI: 10.1016/j.canrad.2020.04.006
Faruque M, Wanschers M, Ligtenberg AJ, Laine ML, Bikker FJ. A review on the role of salivary MUC5B in oral health. J Oral Biosci. 2022;64(4):392–99. DOI: 10.1016/j.job.2022.09.005
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Bulletin of Medical and Biological Research
This work is licensed under a Creative Commons Attribution 4.0 International License.
